Amid a new Ebola outbreak in Kampala, Uganda, the World Health Organization has kicked off a vaccine trial. This is the first ...

Illumina shares tumbled 8% Friday on investor concerns about the future of the gene-sequencing equipment maker’s business in ...

Oxford Nanopore Technologies PLC ( ($GB:ONT) ) has issued an update. Oxford Nanopore Technologies PLC announced a Share Incentive Plan transaction ...

Panelists discuss how therapy sequencing is approached for patients with chronic lymphocytic leukemia (CLL), with a focus on ...

TD Cowen downgraded Illumina (ILMN) to Hold from Buy with a price target of $140, down from $177. Accelerating high throughput next-generation ...

Defining remission is challenging due to imprecise CT/PET scans and genetic heterogeneity of aggressive B-cell lymphomas. Next-generation sequencing tests offer potential for more precise remission ...

Gene sequencing machine maker Illumina forecast 2025 revenue largely below Wall Street estimates on Thursday, signaling ...

UC Santa Cruz genomics experts gained new insights into the campus's endearingly eccentric mascot — and overcame the unique ...

The genomics industry is set for growth due to advancements in personalized medicine, diagnostics, and biotech innovations.

For the first time, a new genotype of avian influenza has been identified in U.S. dairy cows, prompting biosecurity efforts.

Immune cells in the bone marrow microenvironment of AML patients are key in distinguishing a response to immunotherapy.

Finding life on another planet would be a world-changing discovery for humanity. But actually detecting it is no simple task.